Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

CSE/PSYG stock hub

CSE/PSYG has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/PSYGis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.9M

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/PSYG

In the news

Latest news · CSE/PSYG

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-43.1

P25 -121.5P50 -40.9P75 0.5

ROIC-22.3

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/PSYG market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

141

Groups with data

Currency

CAD

Showing 141 of 141 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 1.1M
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	CA74449Q2053
Last refreshed	2026-05-10
Market cap	CAD 1.9M
Price	CAD 0.12
Price currency	CAD
Sector	Healthcare
Sic	2836
Symbol	cse/PSYG
Website	https://psyence.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-58.48%
EV Earnings	-0.98x
EV/FCF	-0.4x
FCF yield	-144.09%
P/B ratio	2.33x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	CAD -1.1M
Net Income Growth Years	1%
ROA	-20.25
ROCE	-258.2
ROE	-43.1
ROIC	-22.29

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-60.02%
Cagr3y	-59.44%
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	CAD 879,664
Cash	CAD 505,423
Current Assets	CAD 866,662
Current Liabilities	CAD 75,242
Equity	CAD 804,422
Interest Coverage	-76.75
Liabilities	CAD 75,242
Long Term Assets	CAD 13,002
Long Term Liabilities	CAD 0
Net Cash	CAD 505,423
Net Cash By Market Cap	CAD 26.93
Net Cash Growth	-95.21%
Net Debt Equity	CAD -0.63
Tangible Book Value	CAD 791,420
Tangible Book Value Per Share	CAD 0.05
WACC	11.17

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	11.52
Net Working Capital	CAD 285,997
Quick ratio	11.47
Working Capital	CAD 791,420

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-51.41%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-60%
200-day SMA	0.23
3Y total return	-93.33%
50-day SMA	0.15
50-day SMA vs 200-day SMA	50under200
All Time High	9.3
All Time High Change	-98.71%
All Time High Date	2021-01-27
All Time Low	0.11
All Time Low Change	14.29%
All Time Low Date	2025-04-25
ATR	0.01
Beta	1.26
Beta1y	0.24
Beta2y	-0.76
Ch YTD	-46.67
High	0.12
High52	0.38
High52 Date	2024-11-25
High52ch	-68%
Low	0.12
Low52	0.11
Low52 Date	2025-04-25
Low52ch	14.29%
Ma50ch	-18.75%
Price vs 200-day SMA	-46.9%
RSI	44.76
RSI Monthly	31.12
RSI Weekly	40.93
Sharpe ratio	1.12x
Sortino ratio	1.95
Total Return	-51.41%
Tr YTD	-46.67
Tr1m	-22.58%
Tr1w	9.09%
Tr3m	-27.27%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -2.1M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	15,568,612%
Net Borrowing	2,574,271
Shares Insiders	3.48%
Shares Out	15,638,267
Shares Qo Q	-25.06%
Shares Yo Y	51.41%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -2.8M
Average Volume	4,652.8x
Bv Per Share	0.05
CAPEX	CAD -143
Ch1m	-22.58
Ch1w	9.09
Ch1y	-60
Ch3m	-27.27
Ch3y	-93.33
Ch6m	-20
Change	9.09%
Change From Open	0
Close	0.11
Days Gap	9.09
Depreciation Amortization	526
Dollar Volume	1,200
Earnings Date	2026-07-28
EBIT	CAD -2.1M
EBITDA	CAD -2.1M
EPS	CAD -0.08
F Score	1
FCF	CAD -2.7M
FCF EV Yield	-252.05x
FCF Per Share	CAD -0.17
Financing CF	1,072,301
Fiscal Year End	March
Founded	2,019
Investing CF	-8,422,496
Is Primary Listing	1
Last Earnings Date	2026-02-27
Last Report Date	2025-12-31
Last Split Date	2025-04-23
Last Split Type	Reverse
Ma150	0.19
Ma150ch	-36.94%
Ma20	0.14
Ma20ch	-11.44%
Net CF	-10,053,941
Next Earnings Date	2026-07-28
Open	0.12
Price Date	2025-11-20
Ptbv Ratio	2.37
Relative Volume	2.15x
Share Based Comp	100,359
Tr6m	-20%
Volume	10,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/PSYG pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/PSYG stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSE/PSYG?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+3.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+51.4%

Negative means the company is buying back shares.

Technical

CSE/PSYG momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.8

Neutral momentum band

Price vs 200-day MA

-46.9%

50/200-day relationship not available

Beta (5Y)

1.26

More volatile than the market

Sharpe ratio

1.12

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/PSYG

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/PSYG stock rating?

cse/PSYG is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/PSYG analysis?

The full report lives at /stocks/cse/PSYG/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/PSYG?

The latest report frames cse/PSYG around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/PSYG page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.